Goldman, Credit Suisse Raided in Seoul in Samsung BioLogics Probe

Prosecutors are reportedly looking for information about a scrapped Nasdaq listing of a Samsung BioLogics subsidiary, to shed light on possible accounting irregularities.

To continue reading...


Get access to Regulation Asia

Regulation Asia delivers the latest news, research and analysis on regulation across banking and capital markets.

Enquire about a subscription today. Get in touch with one of our team or purchase a subscription by clicking below:

Enquire Subscribe

To discuss our subscription options
please email [email protected]

To Top